Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome - PubMed

Affiliations

• PMID: 18809980

Free article

Review

Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome

J Hoekstra et al. Neth J Med. 2008 Sep.

Free article

Abstract

Budd-Chiari syndrome (BCS) is a venous outflow obstruction of the liver that has a dismal outcome if left untreated. Most cases of BCS in the Western world are caused by thrombosis of the hepatic veins, sometimes in combination with thrombosis of the inferior vena cava. Typical presentation consists of abdominal pain, hepatomegaly and ascites, although symptoms may vary significantly. Currently, a prothrombotic risk factor, either inherited or acquired, can be identified in the majority of patients. Moreover, in many patients with BCS a combination of risk factors is present. Myeloproliferative disorders are the most frequent underlying cause, occurring in approximately half of the patients. Recent discovery of the Janus Kinase 2 (JAK2) mutation has significantly contributed to the diagnosis of myeloproliferative disorders. Anticoagulation is indicated for all patients with BCS and additional therapy depends on the severity of symptoms and the extent of venous obstruction. A stepwise therapeutic approach is recommended, with increasing invasiveness and guided by the response to previous treatment. A transjugular intrahepatic portosystemic shunt (TIPS) is proving to be a good therapeutic option in patients with BCS, diminishing the need for surgical shunts. When all other therapy is unsuccessful or in patients with fulminant hepatic failure, a liver transplantation should be considered. Advances in diagnosis and treatment have dramatically improved the prognosis of patients with BCS. Still, many aspects of this complicated disorder remain to be clarified.

Comment in

• Budd-Chiari syndrome.

  Kittisupamongkol W. Kittisupamongkol W. Neth J Med. 2009 Jan;67(1):32; author reply 32. Neth J Med. 2009. PMID: 19155547 No abstract available.

Similar articles

• Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome.

  Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Senzolo M, et al. Nat Clin Pract Gastroenterol Hepatol. 2005 Apr;2(4):182-90. doi: 10.1038/ncpgasthep0143. Nat Clin Pract Gastroenterol Hepatol. 2005. PMID: 16265183 Review.

• Budd-Chiari syndrome/hepatic venous outflow tract obstruction.

  Valla DC. Valla DC. Hepatol Int. 2018 Feb;12(Suppl 1):168-180. doi: 10.1007/s12072-017-9810-5. Epub 2017 Jul 6. Hepatol Int. 2018. PMID: 28685257 Review.

• [Budd-Chiari syndrome--from diagnosis to treatment--case reports].

  Kozielewicz D, Smukalska E, Dybowska D. Kozielewicz D, et al. Pol Merkur Lekarski. 2008 Mar;24(141):260-4. Pol Merkur Lekarski. 2008. PMID: 18634297 Polish.

• Budd-Chiari syndrome.

  Plessier A, Valla DC. Plessier A, et al. Semin Liver Dis. 2008 Aug;28(3):259-69. doi: 10.1055/s-0028-1085094. Epub 2008 Sep 23. Semin Liver Dis. 2008. PMID: 18814079 Review.

• Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.

  Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA. Khuroo MS, et al. J Gastroenterol Hepatol. 2005 Oct;20(10):1494-502. doi: 10.1111/j.1440-1746.2005.03878.x. J Gastroenterol Hepatol. 2005. PMID: 16174064

Cited by

• Budd-Chiari syndrome: a single-center experience.

  Pavri TM, Herbst A, Reddy R, Forde KA. Pavri TM, et al. World J Gastroenterol. 2014 Nov 21;20(43):16236-44. doi: 10.3748/wjg.v20.i43.16236. World J Gastroenterol. 2014. PMID: 25473178 Free PMC article.

• Venous thromboembolic disease.

  Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A. Streiff MB, et al. J Natl Compr Canc Netw. 2011 Jul 1;9(7):714-77. doi: 10.6004/jnccn.2011.0062. J Natl Compr Canc Netw. 2011. PMID: 21715723 Free PMC article. No abstract available.

• Noncirrhotic portal hypertension.

  Rajekar H, Vasishta RK, Chawla YK, Dhiman RK. Rajekar H, et al. J Clin Exp Hepatol. 2011 Sep;1(2):94-108. doi: 10.1016/S0973-6883(11)60128-X. Epub 2011 Nov 9. J Clin Exp Hepatol. 2011. PMID: 25755321 Free PMC article. Review.

• Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression.

  Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Orloff MJ, et al. J Gastrointest Surg. 2012 Feb;16(2):286-300; discussion 300. doi: 10.1007/s11605-011-1738-9. Epub 2011 Nov 8. J Gastrointest Surg. 2012. PMID: 22065317

• Living donor liver transplantation for adult Budd Chiari syndrome - Resection without replacement of retrohepatic IVC: A case report.

  Sabra TA, Okajima H, Tajima T, Fukumitsu K, Hata K, Yasuchika K, Masui T, Taura K, Kaido T, Uemoto S. Sabra TA, et al. Int J Surg Case Rep. 2018;42:50-54. doi: 10.1016/j.ijscr.2017.11.050. Epub 2017 Dec 1. Int J Surg Case Rep. 2018. PMID: 29216531 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • van Zuiden Communications

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal